![](/prequal/sites/default/files/sf_files/sf_finishedpharmaceuticalproduct/BT-ON008.jpg)
Product Details
WHO Product ID
BT-ON008
Status
Prequalified
INN, dosage form and strength
Trastuzumab Powder for concentrate for solution for infusion 150mg
Date of prequalification
Basis of listing
Prequalification - Abridged
Therapeutic area
Oncology
Type
Biotherapeutic Product
Dosage form
Powder for concentrate for solution for infusion
Applicant organization
Biosimilar Collaborations Ireland Limited
Unit 35/36 Grange Parade, Baldoyle Industrial Estate
Dublin,
D13 R20R
Ireland
Packaging details and storage conditions
Packaging Type
Vial, 15 mL clear glass type I
Configuration
1x1
Shelf life (months)
48
Storage conditions
Store in a refrigerator (2 °C to 8 °C)
API Manufacturing Site(s)
By Organization
By Active Ingredient
Biocon Biologics Limited
Special Economic Zone, Plot Nos. 2, 3, 4 & 5 - Phase-IV, Bommasandra-Jigani Link Road, Bommasandra Post
Bangalore,
560 099
India
Trastuzumab
FPP Manufacturing Site(s)
By Organization
By Active Ingredient
Batch release site: McDermott Laboratories
T/A Mylan Dublin Biologics, Newenham Court, Northern Cross, Malahide Road
Dublin, 17,
Ireland
Trastuzumab